Beijing – September 11, 2026 -- Waterdrop Inc. (NYSE: WDH) reported second-quarter 2026 operating revenue of RMB1,448.2 million, up 72.8% year-over-year, with net profit attributable to ordinary shareholders reaching RMB125.8 million, marking the company's 18th consecutive profitable quarter.
The Beijing-based insurance and healthcare technology firm has cumulatively repurchased approximately 62.9 million American Depositary Shares from the open market as of August 31, 2026.
Insurance revenue climbs 80.5% as AI tools drive premium growth
Insurance-related revenue rose 80.5% year-over-year, with operating profit for the segment reaching RMB183.6 million, up 20% quarter-over-quarter. Premiums facilitated through the company's 'AI Medical Insurance Expert' tool increased 25.6% quarter-over-quarter, while first-year premiums for long-term insurance products grew 33.4% quarter-over-quarter.
New products drop health-disclosure requirements for chronic disease patients
Using claims data and user profile analytics, Waterdrop launched 'Rongyibao,' a long-term critical illness insurance product requiring no health disclosure and offering five-year guaranteed renewability across more than 100 critical illnesses. The company also expanded its 'Jixing Gaozhao' series with what it describes as the market's first lifetime specified disease insurance product requiring no health disclosure, targeting users with pre-existing conditions previously excluded under standard underwriting.
Medical crowdfunding platform has channeled RMB74.7 billion to 3.82 million patients since 2016
Waterdrop Medical Crowdfunding has drawn cumulative donations of RMB74.7 billion from roughly 499 million donors to 3.82 million critical-illness patients since the platform's 2016 launch. This quarter, the company deployed large-language-model risk management tools to identify fundraiser sensitive-identity issues and abnormal assets, aiming to strengthen case authenticity verification. AI fundraising assistants now operate in 548 cities nationwide, providing round-the-clock fundraising guidance and basic health education, particularly for users in remote regions.
E-Find clinical trial platform revenue rises 26.8% on expanded pharma partnerships
The company's digital clinical trial solutions unit, E-Find Platform, generated net revenue of RMB35.2 million, up 26.8% year-over-year. The platform established partnerships with 255 domestic and overseas pharmaceutical companies and contract research organizations this quarter. As of June 30, 2026, E-Find had cumulatively delivered 1,873 clinical trial projects with 17,052 enrolled patients.
Company deploys emergency relief following Guangxi flooding and Tibet debris-flow disaster
Waterdrop established a disaster relief emergency response team in response to rainstorms and flooding across Guangxi and a debris-flow disaster at Jilong Port in Shigatse, Tibet. Waterdrop Charity launched a dedicated "Relief" section on its platform and, working with multiple foundations, delivered more than 2,000 relief supply packages to the Guangxi disaster zone.
Founder and CEO Shen Peng said the company views technology as its core driver, with AI embedded across its platforms to capture growing demand in existing businesses.